← Back to Search

Radiation Therapy

Whole Brain IMRT for Brain Tumor

N/A
Waitlist Available
Led By Johnny Kao, MD
Research Sponsored by Good Samaritan Hospital Medical Center, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

In this study the patient will receive either whole brain radiation therapy given by intensity modulated radiation therapy (IMRT) or standard conventional radiation. In IMRT therapy radiation dose to the parts of the brain that do not contain tumors is reduced. This study will look to see if this approach results in less hair loss or fewer memory Problems, as compared to the standard technique. The study will also look at the effectiveness of both techniques in controlling the growth of the tumor.

Eligible Conditions
  • Brain Tumor

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alopecia
Secondary outcome measures
Quality of life
The study will also look at the effectiveness of both techniques in controlling the growth of the tumor.

Trial Design

2Treatment groups
Active Control
Group I: Whole Brain IMRTActive Control1 Intervention
Whole brain radiation therapy delivered via IMRT (37.5 Gy to brain tumor, 30 Gy to the uninvolved brain in 15 fractions), mean dose of less than 18 Gy to scalp.
Group II: Conventional whole brain RTActive Control1 Intervention
Conventional whole brain radiation therapy (37.5 Gy to the brain tumors and uninvolved brain in 15 fractions).

Find a Location

Who is running the clinical trial?

Good Samaritan Hospital Medical Center, New YorkLead Sponsor
5 Previous Clinical Trials
6,820 Total Patients Enrolled
Johnny Kao, MDPrincipal InvestigatorGood Samaritan Hospital Medical Center
2 Previous Clinical Trials
133 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~5 spots leftby Apr 2025